Wolverine Trading, LLC Esperion Therapeutics, Inc. Call Options Transaction History

Wolverine Trading, LLC

$93.9 Billion
Q3 2024

Call Options

21 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	SELL	$1.61 - $2.73 $16,422 - $27,846	-10,200 Reduced 35.54%	18,500 $30,000
Q2 2024 Aug 14, 2024	BUY	$1.84 - $3.24 $52,808 - $92,988	28,700 New	28,700 $63,000
Q3 2023 Nov 15, 2023	BUY	$0.96 - $1.79 $3,840 - $7,160	4,000 Added 37.04%	14,800 $14,000
Q2 2023 Aug 23, 2023	SELL	$1.2 - $1.76 $2,040 - $2,992	-1,700 Reduced 13.6%	10,800 $15,000
Q1 2023 May 15, 2023	SELL	$1.46 - $7.3 $50,516 - $252,580	-34,600 Reduced 73.46%	12,500 $21,000
Q4 2022 Feb 14, 2023	BUY	$5.09 - $8.5 $239,739 - $400,350	47,100 New	47,100 $293,000
Q4 2021 Feb 14, 2022	SELL	$4.81 - $11.92 $123,135 - $305,152	-25,600 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$11.34 - $21.37 $290,304 - $547,072	25,600 New	25,600 $318,000
Q2 2021 Aug 06, 2021	SELL	$19.4 - $28.71 $372,480 - $551,232	-19,200 Closed	0 $0
Q1 2021 May 14, 2021	BUY	$25.12 - $36.89 $482,304 - $708,288	19,200 New	19,200 $527,000
Q2 2020 Aug 13, 2020	SELL	$30.04 - $51.31 $402,536 - $687,554	-13,400 Closed	0 $0
Q1 2020 May 11, 2020	SELL	$27.44 - $73.84 $524,104 - $1.41 Million	-19,100 Reduced 58.77%	13,400 $455,000
Q4 2019 Feb 12, 2020	BUY	$35.4 - $59.82 $187,620 - $317,046	5,300 Added 19.49%	32,500 $1.94 Million
Q3 2019 Nov 14, 2019	BUY	$34.47 - $47.53 $372,276 - $513,324	10,800 Added 65.85%	27,200 $1.03 Million
Q2 2019 Aug 20, 2019	BUY	$40.1 - $52.33 $72,180 - $94,194	1,800 Added 12.33%	16,400 $763,000
Q1 2019 May 15, 2019	SELL	$40.11 - $53.57 $232,638 - $310,706	-5,800 Reduced 28.43%	14,600 $586,000
Q4 2018 Feb 14, 2019	BUY	$36.99 - $59.11 $754,596 - $1.21 Million	20,400 New	20,400 $901,000
Q3 2018 Nov 14, 2018	SELL	$40.74 - $51.41 $1.72 Million - $2.16 Million	-42,100 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$65.94 - $80.76 $619,836 - $759,144	9,400 Added 28.75%	42,100 $3.05 Million
Q4 2017 Feb 14, 2018	BUY	$43.47 - $67.43 $108,675 - $168,575	2,500 Added 8.28%	32,700 $2.15 Million
Q3 2017 Nov 15, 2017	BUY	$43.8 - $52.77 $1.32 Million - $1.59 Million	30,200	30,200 $1.51 Million

Others Institutions Holding ESPR

# of Institutions

208

Shares Held

128M

Call Options Held

1.67M

Put Options Held

930K

View Full List

About Esperion Therapeutics, Inc.

Ticker ESPR
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 66,551,600
Market Cap $160M
Description
Esperion Therapeutics, Inc., a pharmaceutical company, develops and commercializes medicines for the treatment of patients with elevated low density lipoprotein cholesterol. Its lead product candidates are NEXLETOL (bempedoic acid) and NEXLIZET (bempedoic acid and ezetimibe) tablets for the treatment of patients with atherosclerotic cardiovascul...

More about ESPR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wolverine Trading, LLC with notifications on news.

Account